Enjoy complimentary customisation on priority with our Enterprise License!
The soft tissue repair market size is forecast to increase by USD 3.42 billion between 2022 and 2027, accelerating at a CAGR of 4.5%. The growth of the market is driven by an uptick in accidental injuries and the increasing global geriatric population. Additionally, the availability of reimbursements for soft tissue repair products further fuels market expansion. However, challenges persist due to the high expenses and failure rates in clinical trials, along with complications associated with these products. Furthermore, stringent regulations pose obstacles to obtaining product approvals. Despite these hurdles, the market's upward trajectory remains promising, driven by a growing demand for effective solutions to address soft tissue injuries and the aging population's healthcare needs. Overcoming these challenges requires innovative approaches to streamline clinical trial processes, enhance product safety, and navigate regulatory requirements, ensuring continued market growth and advancement in soft tissue repair technologies.
To learn more about this report, Download Report Sample
The report includes a comprehensive outlook on the market, offering forecasts for the industry segmented by End-User, which comprises Hospitals, Ambulatory surgical services, and Clinics. Additionally, it categorizes Product into Soft tissue fixation devices and accessories, Cell therapy, and Tissue scaffolds and covers Geography regions, including North America, Europe, Asia, and Rest of World (ROW). The report provides market size, historical data spanning from 2017 to 2021, and future projections, all presented in terms of value in (USD billion) for each of the mentioned segments.
The market share growth by the hospitals segment will be significant during the forecast period and was valued at USD 7.02 billion in 2017. Hospitals are the main end users influencing the growth of the market. The orthopedic soft tissue repair product manufacturers focus on providing high-quality products to hospitals to enhance their brand /image and thereby expand their product reach. To increase the effectiveness of treatment, hospitals are applying this device to diagnose diabetic retinopathy, cardiovascular disease, and dermatology. Large hospitals such as general hospitals have over 500 beds, providing accommodation for individuals from the locality and surrounding areas. The demand for soft tissue repair products in the hospital will increase due to the increasing number of hospitalizations for surgical care. Medium-sized hospitals have a limited number of providers. The number of emergency room visits is increasing due to the increasing number of traumatic brain and orthopedic injuries. This will increase sales of orthopedic soft tissue repair products in mid-sized hospitals. Hence, these factors will fuel the growth of the hospital segment of the global soft tissue repair market during the forecast period.
North America is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. Due to the growing demand for stem cell and tissue products designed to treat various diseases, increased funding in the US from the National Institutes of Health (NIH) and the Agency for Research and Biomedical Advanced Development (BARDA) will support product development. The potential of these products is one of the key factors driving the market in North America. For cell therapy, the application of stem cells and advances in nanotechnology will represent further advancement in this market.
Furthermore, market players like Medtronic and others have increased investment in R&D to develop innovative medical therapies, which is driving the overall growth of the market. The market is quite fragmented, with the presence of many large and small players. The market is also witnessing an increase in the number of mergers and acquisitions and strategic supplier alliances, which will have a remarkable impact on the growth of the market by increasing the number of products and developing new products. Therefore, such factors will drive the growth of the market in this region during the forecast period.
To understand geographic trends Download Report Sample
The field of soft tissue repair encompasses a broad array of medical conditions and injuries, ranging from trauma patients and sports injuries to diseases like cystic fibrosis and hepatitis, as well as cardiovascular disorders and rotator cuff tears. Orthopedic surgeries address issues such as strains, tendon damage, and ligament tears, often resulting from road traffic crashes or sports-related incidents. Techniques like suturing play a crucial role in orthopedic procedures and trauma injuries, facilitating effective soft tissue repair. Soft tissue repair products, including those developed by Aroa Biosurgery, aim to restore muscle, fibrous tissue, and connective tissues, promoting tissue repair and regeneration. This field serves diverse demographics, including the elderly population, and addresses the critical need for soft tissue restoration following various soft tissue injuries and surgeries.
The number of elderly people has raised due to longer life expectancy and this number is expected to increase sharply during the forecast period. Important skeletal and neuromuscular changes due to aging can lead to arthritis, weak ligaments, and tearing of the ACL. The growing number of elderly people has increased the demand for orthopedic procedures worldwide. According to the Census Bureau, by 2060 there will be 95 Billion Americans age 65 or older, up from about 52 Billion in 2018, and the share of people 65 and older is expected to grow from 16%. at 23%. Hence, the increasing demand for acute and long-term healthcare services is expected to propel the growth of the global market during the forecast period.
The market is fragmented in nature. Some significant players include 3M Co., Acera Surgical Inc., AlloSource, Arthrex Inc., Artivion Inc.
The research report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:
Becton Dickinson and Co., Conmed Corp., Ed. Geistlich Sohne AG, Integra Lifesciences Corp., Johnson and Johnson, JRF Ortho, Koninklijke DSM NV, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2023 to 2027, as well as historical data from 2017 to 2021 for the following segments
The market encompasses a broad spectrum of medical needs, from addressing trauma injuries and sports-related incidents to managing chronic conditions such as diabetes-related gangrene and osteoporosis-related fractures. Surgeons perform intricate procedures like transabdominal preperitoneal (TAPP) repair and completely extraperitoneal (TEP) repair to rectify issues such as hernias and rotator cuff tears. Innovative technologies like resorbable polymer technology and synthetic mesh are deployed in orthopedic surgeries and hernia repair, ensuring effective tissue repair and regeneration. Companies like Aroa Biosurgery offer a diverse surgical mesh portfolio for various applications, while ongoing clinical trials explore advancements in soft tissue restoration. Skilled surgeons in surgical care facilities and ambulatory surgery centers play a pivotal role, highlighting the importance of regulatory approval and continued research in this field.
The market caters to a broad spectrum of medical needs, from addressing trauma in patients and sports injuries to managing chronic conditions such as obesity, osteoporosis, and rheumatoid arthritis. Surgeons perform intricate procedures involving various tissues like muscle, fibrous tissue, and connective tissues, utilizing advanced techniques and materials such as tissue patches, extracellular matrix, and synthetic materials. This market serves a wide demographic, including the geriatric population facing age-related physiological changes and the growing segment of baby boomers. From orthopedic surgeries to dental and breast reconstruction repairs, soft tissue repair encompasses a myriad of medical interventions, highlighting the crucial role of physicians and ongoing advancements in biomaterials and biologics. Additionally, innovations in orthopedic trauma devices and power tools contribute to the efficacy of surgical procedures, ensuring optimal patient outcomes across various medical specialties.
Moreover, the market serves a diverse range of medical needs, from addressing traumatic injuries in patients and obesity-related concerns to managing chronic conditions such as musculoskeletal disorders, osteoarthritis, and cancer. Surgeons utilize advanced techniques and materials like tissue patches and mesh to repair various tissues affected by injuries or diseases. This market caters to a wide demographic, including trauma patients, the elderly population, and individuals seeking orthopedic surgeries or dental repairs. From treating soft tissue injuries caused by accidents or sports-related incidents to addressing congenital disorders and infections, soft tissue repair plays a crucial role in restoring health and mobility. Ongoing advancements in biological products and orthopedic trauma devices continue to enhance treatment options and patient outcomes in this field.
Soft Tissue Repair Market Scope |
|
Report Coverage |
Details |
Page number |
163 |
Base year |
2022 |
Historic period |
2017 - 2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market growth 2023-2027 |
USD 3.42 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
3.86 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 34% |
Key countries |
US, Germany, France, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., Acera Surgical Inc., AlloSource, Arthrex Inc., Artivion Inc., Becton Dickinson and Co., Conmed Corp., Ed. Geistlich Sohne AG, Integra Lifesciences Corp., Johnson and Johnson, JRF Ortho, Koninklijke DSM NV, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc. |
Market dynamics |
Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the market forecast period. |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.